UPDATE: Sartorius Reports Profitable Growth in 2025, Forecasts Continued Gains
• Group sales revenue for 2025 increased by 7.6% in constant currencies to approximately €3.5 billion. • Underlying EBITDA margin rose to 29.7%,…
UPDATE: Givaudan to Invest USD 110 Million in Mexico Fragrance Facility
• USD 110 million investment in a new fragrance compounding facility in Pedro Escobedo, Mexico. • The plant is expected to be operational…
UPDATE: Sika Opens New Plants in US, Argentina, Colombia, Bangladesh, Tanzania
• New facilities are located in the US, Argentina, Colombia, Bangladesh, and Tanzania. • The expansion targets growing regional demand for high-performance construction…
UPDATE: Denmark Signs Major Ammunition Deal With Rheinmetall
• Denmark and Rheinmetall signed a seven-year framework agreement for ammunition supply on January 30, 2026. • Initial orders for tank and medium-calibre…
UPDATE: Lenzing Buy Majority in Sweden’s TreeToTextile AB
• Lenzing AG acquires controlling majority in TreeToTextile AB to accelerate new fiber industrialization LENZING, Austria – The Lenzing Group announced on February…
UPDATE: CA Immo completes sale of Millennium Tower I in Budapest
• CA Immo completes sale of Millennium Tower I in Budapest BUDAPEST, Hungary – Real estate company CA Immo has completed the sale…
UPDATE: NFL Stars Launch Prostate Cancer Awareness Campaign at Super Bowl LX
Titled “Relax, it’s a blood test” Novartis and NFL Stars Launch Prostate Cancer Awareness Campaign at Super Bowl LX EAST HANOVER, United States…
UPDATE: Rheinmetall signs multi-year contract to supply hand grenades to the Dutch Army
• Rheinmetall signs multi-year contract to supply hand grenades to the Dutch Army DÜSSELDORF, Germany – Technology group Rheinmetall has signed a multi-year…
UPDATE: Liberia and ArcelorMittal Finalize Mineral Development Agreement to 2050
• Liberia and ArcelorMittal Finalize Mineral Development Agreement to 2050 MONROVIA, Liberia – The Government of Liberia and ArcelorMittal have finalized an amended…
UPDATE: UCB Receives Positive EU Recommendation for First-Ever Thymidine Kinase 2 Deficiency Treatment
• UCB Receives Positive EU Recommendation for First-Ever Thymidine Kinase 2 Deficiency Treatment BRUSSELS, Belgium – Global biopharmaceutical company UCB announced on January…